Company Filing History:
5 out of 1,327 
4 out of 27 
1 out of 1 Years Active: 1999-2013
Title: Grace E. Gray: Innovator in Delta Protein Research
Introduction
Grace E. Gray is a prominent inventor based in New Haven, CT, known for her significant contributions to the field of biotechnology. With a total of eight patents to her name, she has made remarkable advancements in the understanding and application of Delta proteins. Her work has implications for therapeutic and diagnostic methods, showcasing her innovative spirit and dedication to scientific progress.
Latest Patents
Among her latest patents, Grace E. Gray has developed a method of treatment using a soluble human delta protein fragment. This invention relates to nucleotide sequences of vertebrate Delta genes and the amino acid sequences of their encoded proteins. It includes derivatives and analogs of these proteins, specifically focusing on human proteins. The invention encompasses fragments of Delta that comprise various domains, such as the intracellular domain, extracellular domain, DSL domain, and transmembrane region. Additionally, it provides antibodies to Delta and its derivatives, along with methods for producing these proteins through recombinant means. Therapeutic and diagnostic methods, as well as pharmaceutical compositions, are also part of her innovative contributions.
Career Highlights
Grace E. Gray has had a distinguished career, working with esteemed institutions such as Yale University and Imperial Cancer Research Technology, Ltd. Her research has not only advanced scientific knowledge but has also paved the way for new therapeutic approaches in medicine.
Collaborations
Throughout her career, she has collaborated with notable colleagues, including David Ish-Horowicz and Julian Hart Lewis. These partnerships have further enriched her research and expanded the impact of her inventions.
Conclusion
Grace E. Gray's work in the field of Delta protein research exemplifies her innovative contributions to biotechnology. Her patents and collaborations highlight her commitment to advancing scientific knowledge and improving therapeutic methods.